Mednax Inc (MD)
Return on assets (ROA)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | -60,408 | 93,538 | 102,875 | 101,729 | 66,335 | 84,192 | 84,259 | 92,134 | 130,964 | 19,152 | -52,687 | -760,134 | -796,488 | -722,861 | -1,937,737 | -1,273,546 | -1,497,706 | -1,446,823 | -125,328 | -37,671 |
| Total assets | US$ in thousands | 2,219,810 | 2,326,340 | 2,305,510 | 2,320,050 | 2,347,890 | 2,331,960 | 2,369,620 | 2,340,980 | 2,722,550 | 2,646,100 | 2,555,130 | 2,483,740 | 3,347,950 | 3,424,830 | 3,387,210 | 4,319,660 | 4,145,900 | 4,290,660 | 5,638,810 | 5,706,260 |
| ROA | -2.72% | 4.02% | 4.46% | 4.38% | 2.83% | 3.61% | 3.56% | 3.94% | 4.81% | 0.72% | -2.06% | -30.60% | -23.79% | -21.11% | -57.21% | -29.48% | -36.12% | -33.72% | -2.22% | -0.66% |
December 31, 2023 calculation
ROA = Net income (ttm) ÷ Total assets
= $-60,408K ÷ $2,219,810K
= -2.72%
The return on assets (ROA) of Pediatrix Medical Group Inc has shown some fluctuations over the past few quarters. In Q4 2023, the ROA was negative at -2.72%, indicating that the company's net income generated from its assets was insufficient to cover its total assets. However, in the previous quarters, the ROA was positive, with values ranging from 3.56% to 4.46%.
The positive ROA values in Q3, Q2, and Q1 2023 indicate that the company was able to generate a profit from its assets during those periods. This trend was consistent with the performance in Q4 2022, where the ROA was also positive at 2.83%.
Overall, the recent ROA values suggest that Pediatrix Medical Group Inc has been successful in utilizing its assets to generate profits, with some variability in performance seen in Q4 2023. It would be important to further investigate the factors behind this negative ROA in Q4 2023 to understand its impact on the company's overall financial health and profitability.
Peer comparison
Dec 31, 2023